Northwestern Medicine Developmental Therapeutics Institute
Developmental Therapeutics is a broad area of study that includes basic research aimed at finding new targets for anticancer agents, preclinical testing of new drugs or cell and immune therapies for cancer treatment, and clinical trials to test new agents in people.
The Northwestern Medicine Developmental Therapeutics Institute (NMDTI) has been launched to accelerate the translation of preclinical science breakthroughs so as to develop better therapies for our patients.
New approaches are being used to prevent cancer, better predict its causes and improve its treatment. NMDTI will be offering patients the most advanced clinical trial and treatment options available.
Our ability to call upon the world-class resources of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, the research and medical expertise of the Northwestern University Feinberg School of Medicine and Northwestern Medical Group, and the preeminent healthcare facilities of Northwestern Memorial Hospital allows the NMDTI to provide patients with the best possible care
News & Events
Northwestern Developmental Therapeutics Institute (NMDTI) opens, offering novel therapeutic approaches for the treatment of cancer and other life-threatening diseases.
Meet Our Team
Areas of Clinical Expertise